Lantheus Holdings (LNTH) Research & Development (2014 - 2026)
Lantheus Holdings (LNTH) reported Research & Development of $39.4 million for Q1 2026, up 8.44% year-over-year from $36.3 million in Q1 2025, and up 133.2% quarter-over-quarter from -$118.6 million in Q4 2025.
Lantheus Holdings (LNTH) Research & Development (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Research & Development data on file, last reported at $39.4 million in Q1 2026.
- Research & Development for Q1 2026 came in at $39.4 million, up 8.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.3 million (down 91.91% YoY), and the FY2025 annual result was $11.2 million, down 93.34% from the prior year.
- Research & Development grew to $39.4 million in Q1 2026 per LNTH's latest filing, from -$118.6 million in the prior quarter.
- Over five years, Research & Development peaked at $220.5 million in Q4 2022 and troughed at -$118.6 million in Q4 2025.
- A 5-year average of $32.7 million and a median of $30.5 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development soared 1852.94% in 2022, then slumped 372.73% in 2025.
- A 5-year view of Research & Development shows it stood at $220.5 million in 2022, then tumbled by 92.37% to $16.8 million in 2023, then jumped by 158.54% to $43.5 million in 2024, then tumbled by 372.73% to -$118.6 million in 2025, then surged by 133.2% to $39.4 million in 2026.
- Business Quant data shows LNTH's Research & Development at $39.4 million in Q1 2026, -$118.6 million in Q4 2025, and $48.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 12.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.38 Mn |
| Dec 31, 2025 | -118.63 Mn |
| Sep 30, 2025 | 48.03 Mn |
| Jun 30, 2025 | 45.49 Mn |
| Mar 31, 2025 | 36.31 Mn |
| Dec 31, 2024 | 43.50 Mn |
| Sep 30, 2024 | 36.00 Mn |
| Jun 30, 2024 | 60.60 Mn |
| Mar 31, 2024 | 28.00 Mn |
| Dec 31, 2023 | 16.82 Mn |
| Sep 30, 2023 | 14.45 Mn |
| Jun 30, 2023 | 15.90 Mn |
| Mar 31, 2023 | 30.53 Mn |
| Dec 31, 2022 | 220.55 Mn |
| Sep 30, 2022 | 12.52 Mn |
| Jun 30, 2022 | 14.74 Mn |
| Mar 31, 2022 | 12.20 Mn |
| Dec 31, 2021 | 11.29 Mn |
| Sep 30, 2021 | 11.25 Mn |
| Jun 30, 2021 | 12.06 Mn |